<bill session="109" type="h" number="4769" updated="2023-01-13T04:49:09Z">
  <state datetime="2006-02-16">REFERRED</state>
  <status>
    <introduced datetime="2006-02-16"/>
  </status>
  <introduced datetime="2006-02-16"/>
  <titles>
    <title type="display">Prescription Drug Abuse Elimination Act of 2006</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act, the Controlled Substances Import and Export Act, and the Public Health Service Act to impose requirements respecting Internet pharmacies, to require manufacturers to implement chain-of-custody procedures, to restrict an exemption respecting the importation of controlled substances for personal use, and for other purposes.</title>
    <title type="short" as="introduced">Prescription Drug Abuse Elimination Act of 2006</title>
  </titles>
  <sponsor bioguide_id="N000159"/>
  <cosponsors>
    <cosponsor bioguide_id="B001228" joined="2006-04-25"/>
    <cosponsor bioguide_id="B000657" joined="2006-11-14"/>
    <cosponsor bioguide_id="C001037" joined="2006-09-13"/>
    <cosponsor bioguide_id="C001055" joined="2006-04-25"/>
    <cosponsor bioguide_id="C001061" joined="2006-03-14"/>
    <cosponsor bioguide_id="E000187" joined="2006-09-25"/>
    <cosponsor bioguide_id="F000043" joined="2006-04-25"/>
    <cosponsor bioguide_id="F000450" joined="2006-11-14"/>
    <cosponsor bioguide_id="G000550" joined="2006-03-14"/>
    <cosponsor bioguide_id="G000309" joined="2006-03-29"/>
    <cosponsor bioguide_id="J000032" joined="2006-07-28"/>
    <cosponsor bioguide_id="J000070" joined="2006-03-14"/>
    <cosponsor bioguide_id="L000563" joined="2006-09-06"/>
    <cosponsor bioguide_id="L000562" joined="2006-03-14"/>
    <cosponsor bioguide_id="M000309" joined="2006-09-29"/>
    <cosponsor bioguide_id="M001147" joined="2006-12-06"/>
    <cosponsor bioguide_id="P000373" joined="2006-06-27"/>
    <cosponsor bioguide_id="P000589" joined="2006-05-19"/>
    <cosponsor bioguide_id="P000586" joined="2006-03-29"/>
    <cosponsor bioguide_id="R000572" joined="2006-04-25"/>
    <cosponsor bioguide_id="S001162" joined="2006-07-28"/>
    <cosponsor bioguide_id="S001004" joined="2006-02-16"/>
  </cosponsors>
  <actions>
    <action datetime="2006-02-16">
      <text>Introduced in House</text>
    </action>
    <action datetime="2006-02-16" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2006-02-17">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Accreditation (Medical care)"/>
    <term name="Administrative procedure"/>
    <term name="Business records"/>
    <term name="Commerce"/>
    <term name="Communication in medicine"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Consumer education"/>
    <term name="Crime and Law Enforcement"/>
    <term name="Data banks"/>
    <term name="Death"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug abuse"/>
    <term name="Drug addiction"/>
    <term name="Drug industry"/>
    <term name="Drug law enforcement"/>
    <term name="Drugs"/>
    <term name="Economics and Public Finance"/>
    <term name="Electronic commerce"/>
    <term name="Electronic data interchange"/>
    <term name="Federal advisory bodies"/>
    <term name="Federal aid to health facilities"/>
    <term name="Federal-state relations"/>
    <term name="Foreign Trade and International Finance"/>
    <term name="Generic drugs"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Governmental investigations"/>
    <term name="Health information systems"/>
    <term name="Health surveys"/>
    <term name="Identification devices"/>
    <term name="Import restrictions"/>
    <term name="Imports"/>
    <term name="Injunctions"/>
    <term name="Intellectual property"/>
    <term name="Interactive media"/>
    <term name="Internet"/>
    <term name="Labeling"/>
    <term name="Law"/>
    <term name="Medical personnel"/>
    <term name="Medical records"/>
    <term name="Medical statistics"/>
    <term name="Medication abuse"/>
    <term name="Packaging"/>
    <term name="Pharmacies"/>
    <term name="Pharmacists"/>
    <term name="Product counterfeiting"/>
    <term name="Science, Technology, Communications"/>
    <term name="Web sites"/>
  </subjects>
  <amendments/>
  <summary date="2006-04-19T20:42:43Z" status="Introduced in House">Prescription Drug Abuse Elimination Act of 2006 -Amends the Federal Food, Drug, and Cosmetic Act to require Internet pharmacies to meet specified criteria, including: (1) providing individuals who access the pharmacy with certain information; (2) obtaining verification of a valid prescription in some circumstances; and (3) providing contact information of the individual dispensing prescription drugs on the site to each state that licenses or authorizes the person to dispense drugs. Prohibits the sale of a prescription drug, or the ownership or operation of an illegal Internet pharmacy, in violation of the requirements of this Act. Allows district courts to order Internet providers to remove access or links to sites that violate this Act.

Directs the Secretary of Health and Human Services to promulgate chain-of-custody requirements to track prescription drugs from the manufacturer through each importer, distributor, and retailer. Deems a drug misbranded if such requirements are not met.

Amends the Controlled Substances Import and Export Act to restrict the importation of a schedule II, III, or IV drug by a U.S. resident without a valid prescription to once during any 30-day period.

Requires the Secretary, acting through the Commissioner of Food and Drugs, to: (1) convene a working group to study and report on pharmaceutical counterfeiting; and (2) study the best methods to ensure that controlled substances are not diverted for unlawful use.

Requires the Secretary to conduct research and report on issues related to prescription drug abuse.

Requires the Administrator of the Substance Abuse and Mental Health Services Administration to maintain a comprehensive, national database on deaths occurring as a result of substance abuse.</summary>
</bill>
